Serum levels of interleukin-1b, tumour necrosis factor-a and interleukin-2 in rheumatoid arthritis. Correlation with disease activity
- 1 June 1992
- journal article
- research article
- Published by Springer Nature in Clinical Rheumatology
- Vol. 11 (2) , 202-205
- https://doi.org/10.1007/bf02207957
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritisArthritis & Rheumatism, 1990
- Detection of tumor necrosis factor α but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serumArthritis & Rheumatism, 1988
- Elevated soluble interleukin‐2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritisArthritis & Rheumatism, 1988
- Augmented interleukin‐1 production and hla–dr expression in the synovium of rheumatoid arthritis patientsArthritis & Rheumatism, 1988
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Role of Cytokines in Rheumatoid SynovitisScandinavian Journal of Rheumatology, 1988
- Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.The Journal of Experimental Medicine, 1986
- Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.The Journal of Experimental Medicine, 1985
- Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosusClinical Immunology and Immunopathology, 1984
- An interleukin 1 like factor stimulates bone resorption in vitroNature, 1983